Biomerieux 69 Marcy L'Etoile revenue breakdown overview

Biomerieux 69 Marcy L'Etoile revenue for the last year amounted to 4.06 B USD, the most of which — 3.42 B USD — came from its highest performing source at the moment, Clinical Applications, the year earlier bringing 3.25 B USD. The greatest contribution to the revenue figure was made by Americas — last year it brought Biomerieux 69 Marcy L'Etoile 2.04 B USD, and the year before that — 1.97 B USD.